HUMA
Price:
$5.27
Market Cap:
$628.98M
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodia...[Read more]
Industry
Biotechnology
IPO Date
2020-12-01
Stock Exchange
NASDAQ
Ticker
HUMA
According to Humacyte, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.41. This represents a change of -13.72% compared to the average of 6.27 of the last 4 quarters.
The mean historical Current Ratio of Humacyte, Inc. over the last ten years is 9.12. The current 5.41 Current Ratio has changed 5.84% with respect to the historical average. Over the past ten years (40 quarters), HUMA's Current Ratio was at its highest in in the December 2021 quarter at 20.75. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
9.12
Median
7.88
Minimum
3.69
Maximum
20.75
Discovering the peaks and valleys of Humacyte, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 462.47%
Maximum Annual Current Ratio = 20.75
Minimum Annual Increase = -62.05%
Minimum Annual Current Ratio = 3.69
Year | Current Ratio | Change |
---|---|---|
2023 | 4.52 | -42.67% |
2022 | 7.88 | -62.05% |
2021 | 20.75 | 462.47% |
2020 | 3.69 | -57.87% |
The current Current Ratio of Humacyte, Inc. (HUMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.05
5-year avg
9.12
10-year avg
9.12
Humacyte, Inc.’s Current Ratio is less than Crinetics Pharmaceuticals, Inc. (16.09), less than Viridian Therapeutics, Inc. (15.82), less than Cytokinetics, Incorporated (10.39), less than Structure Therapeutics Inc. (41.38), less than Icosavax, Inc. (18.06), greater than Immunocore Holdings plc (5.17), greater than Mirum Pharmaceuticals, Inc. (3.28), less than Larimar Therapeutics, Inc. (10.93), less than KalVista Pharmaceuticals, Inc. (8.55), greater than Lyra Therapeutics, Inc. (3.60), less than Theseus Pharmaceuticals, Inc. (29.93), less than Kura Oncology, Inc. (14.94), less than Nurix Therapeutics, Inc. (5.57), less than Seer, Inc. (17.59), less than Quantum-Si incorporated (20.57), greater than HCW Biologics Inc. (0.10), less than MediciNova, Inc. (18.24),
Company | Current Ratio | Market cap |
---|---|---|
16.09 | $4.03B | |
15.82 | $900.21M | |
10.39 | $6.36B | |
41.38 | $2.11B | |
18.06 | $769.04M | |
5.17 | $1.67B | |
3.28 | $1.96B | |
10.93 | $513.64M | |
8.55 | $531.63M | |
3.60 | $17.85M | |
29.93 | $181.50M | |
14.94 | $1.48B | |
5.57 | $1.50B | |
17.59 | $100.74M | |
20.57 | $129.66M | |
0.10 | $26.62M | |
18.24 | $103.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Humacyte, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Humacyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Humacyte, Inc.'s Current Ratio?
How is the Current Ratio calculated for Humacyte, Inc. (HUMA)?
What is the highest Current Ratio for Humacyte, Inc. (HUMA)?
What is the 3-year average Current Ratio for Humacyte, Inc. (HUMA)?
What is the 5-year average Current Ratio for Humacyte, Inc. (HUMA)?
How does the current Current Ratio for Humacyte, Inc. (HUMA) compare to its historical average?